XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.8.0.1

5) Stock-based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2017
Notes |
5) Stock-based Compensation | 5) Stock Compensation Plans The Company has four fixed option plans (the “2003 Plan”, the “2006 Director Plan”, the “2013 Plan” and the “2014 Director Plan”). Compensation expense for options issued of $102,429 and $84,949 has been recognized for these plans for the three months ended September 30, 2017 and 2016, respectively, and $305,741 and $253,427 for the nine months ended September 30, 2017 and 2016, respectively. As of September 30, 2017, the total unrecognized compensation expense related to the options issued was $69,719, which is expected to be recognized over the vesting period of one year. The Company generally estimates the expected life of the options based upon the contractual term of the options adjusted for actual experience. Future volatility is estimated based upon the weighted historical volatility of the Company’s Class A common stock over a period equal to the estimated life of the options. Common stock issued upon exercise of stock options are generally new share issuances rather than from treasury shares. A summary of the status of the Company’s stock compensation plans as of September 30, 2017, and the changes during the nine months ended September 30, 2017, are presented below:
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price |
Outstanding at December 31, 2016 |  | 741,973 |  | $ 4.33 |  | 556,298 |  | $ 4.61 |
Granted |  | - |  |  |  | - |  |  |
Exercised |  | - |  |  |  | (103,402) |  | 1.31 |
Cancelled |  | - |  |  |  | (24,227) |  | 1.31 |
Outstanding at September 30, 2017 |  | 741,973 |  | $ 4.33 |  | 428,669 |  | $ 5.59 |
As of September 30, 2017: |  |  |  |  |  |  |  |  |
Options exercisable |  | 706,854 |  | $ 4.21 |  | 407,669 |  | $ 5.50 |
As of September 30, 2017: |  |  |  |  |  |  |  |  |
Available options for future grant |  | 525,682 |  |  |  | 227,750 |  |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |  |
outstanding at September 30, 2017 |  | 6.62 years |  |  |  | 2.63 years |  |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |  |
exercisable at September 30, 2017 |  | 6.50 years |  |  |  | 2.55 years |  |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |  |
outstanding at September 30, 2017 (1) |  | $941,567 |  |  |  | $151,012 |  |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |  |
exercisable at September 30, 2017 (1) |  | $941,311 |  |  |  | $151,012 |  |  |
(1) The Company used a stock price of $5.10 as of September 30, 2017 to derive intrinsic value. |
A summary of the status of the Company’s stock compensation plans as of September 30, 2016, and the changes during the nine months ended September 30, 2016, are presented below:
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at December 31, 2015 |  | 618,261 |  | $ 3.89 |  | 577,436 |  | $ 3.54
Granted |  | - |  |  |  | - |  |
Exercised |  | (32,417) |  | 2.38 |  | - |  |
Cancelled |  | - |  |  |  | - |  |
Outstanding at September 30, 2016 |  | 585,844 |  | $ 3.97 |  | 577,436 |  | $ 3.54
As of September 30, 2016: |  |  |  |  |  |  |  |
Options exercisable |  | 550,792 |  | $ 3.82 |  | 551,186 |  | $ 3.38
As of September 30, 2016: |  |  |  |  |  |  |  |
Available options for future grant |  | 397,342 |  |  |  | 57,750 |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
outstanding at September 30, 2016 |  | 6.99 years |  |  |  | 2.00 years |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
exercisable at September 30, 2016 |  | 6.86 years |  |  |  | 1.90 years |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
outstanding at September 30, 2016 (1) |  | $1,179,541 |  |  |  | $1,460,167 |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
exercisable at September 30, 2016 (1) |  | $1,179,541 |  |  |  | $1,460,167 |  |
(1) The Company used a stock price of $5.86 as of September 30, 2016 to derive intrinsic value.
The total intrinsic value (which is the amount by which the fair value of the underlying stock exceeds the exercise price of an option on the exercise date) of stock options exercised during the nine months ended September 30, 2017 and 2016 was $578,017 and $98,663, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration